Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring <i>MET</i> Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in Nonclinical ModelsLars D. Engstrom, James G. Christensen, Curt J. Essenburg et al.|Clinical Cancer Research|2017Cited by 147
Discovery of Aryloxy Tetramethylcyclobutanes as Novel Androgen Receptor AntagonistsChuangxing Guo, Andrea Fanjul, Angelica Linton et al.|Journal of Medicinal Chemistry|2011Cited by 69